P. Attia

发表

Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration

S. Rosenberg, D. Powell, V. Ghetie, 2008, Journal of immunotherapy.

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

S. Rosenberg, J. Yang, A. Maker, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

S. Rosenberg, A. Maker, L. Rogers-Freezer, 2005, Journal of immunotherapy.

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

S. Rosenberg, J. Yang, A. Maker, 2005, Annals of Surgical Oncology.

Selective Elimination of Human Regulatory T Lymphocytes In Vitro With the Recombinant Immunotoxin LMB-2

I. Pastan, S. Rosenberg, D. Powell, 2006, Journal of immunotherapy.

Patients Treated with CTLA-4 Blockade Antitumor Responses and Autoimmunity in Analysis of the Cellular Mechanism of

S. Rosenberg, A. Maker, P. Attia, 2005 .

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-CTLA-4

P. Attia, S. Rosenberg, Phan Q. Giao, 2005 .

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.

S. Steinberg, S. Rosenberg, D. White, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade

S. Rosenberg, A. Maker, P. Attia, 2005, The Journal of Immunology.

Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

S. Rosenberg, J. Yang, A. Maker, 2006, Journal of immunotherapy.

Factors A ssociated W ith R esponse t o H igh-Dose Interleukin-2 i n P atients W ith M etastatic M elanoma

S. Steinberg, S. Rosenberg, D. White, 2001 .

Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

Robert Krikorian, Lisa Mosconi, Peter Attia, 2018, Front. Aging Neurosci..

Individualized clinical management of patients at risk for Alzheimer's dementia

L. Mosconi, J. Safdieh, S. Hendrix, 2019, Alzheimer's & Dementia.

Parathyroid Hormone-Related Protein and Hypercalcemia in Patients With Metastatic Melanoma: Case Report and Review

P. Duray, S. Rosenberg, G. Phan, 2003, American Journal of Clinical Oncology.